These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 17786457)

  • 1. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
    Yamada M; Tan CF; Inenaga C; Tsuji S; Takahashi H
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):665-75. PubMed ID: 15541006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polyglutamine diseases: a pathologic view].
    Yamada M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathogenesis of motor neuron diseases].
    Sobue G
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways.
    Gunawardena S; Goldstein LS
    Arch Neurol; 2005 Jan; 62(1):46-51. PubMed ID: 15642849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology of polyglutamine diseases].
    Owecki M; Kozubski W
    Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
    Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
    Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative polyglutamine expansion diseases: physiopathology and therapeutic strategies].
    Ravache M; Abou-Sleymane G; Trottier Y
    Pathol Biol (Paris); 2010 Oct; 58(5):357-66. PubMed ID: 20299163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trinucleotide repeat expansion in neurological disease.
    La Spada AR; Paulson HL; Fischbeck KH
    Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
    Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
    BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
    Yamada M; Shimohata M; Sato T; Tsuji S; Takahashi H
    Neuropathology; 2006 Aug; 26(4):346-51. PubMed ID: 16961072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal atrophy and synaptic alteration in a mouse model of dentatorubral-pallidoluysian atrophy.
    Sakai K; Yamada M; Sato T; Yamada M; Tsuji S; Takahashi H
    Brain; 2006 Sep; 129(Pt 9):2353-62. PubMed ID: 16891319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Tallaksen-Greene SJ; Ordway JM; Crouse AB; Jackson WS; Detloff PJ; Albin RL
    J Comp Neurol; 2003 Oct; 465(2):205-19. PubMed ID: 12949782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamic mutations in hereditary neurodegenerative disorders].
    Nilssen O
    Tidsskr Nor Laegeforen; 1999 Aug; 119(20):3021-7. PubMed ID: 10504853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of SCA3 and implications for other polyglutamine diseases.
    McLoughlin HS; Moore LR; Paulson HL
    Neurobiol Dis; 2020 Feb; 134():104635. PubMed ID: 31669734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genomic instability and neurodegenerative disease].
    Miki T; Yamagata H
    Rinsho Byori; 1999 Jan; 47(1):37-45. PubMed ID: 10067364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of CAG repeat diseases.
    Yamada M; Tsuji S; Takahashi H
    Neuropathology; 2000 Dec; 20(4):319-25. PubMed ID: 11211058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic mutation and human disorders: the spinocerebellar ataxias (review).
    Costa Lima MA; Pimentel MM
    Int J Mol Med; 2004 Feb; 13(2):299-302. PubMed ID: 14719138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autosomal dominant spinocerebellar ataxia].
    Legros B; Manto MU
    Rev Med Brux; 1999 Dec; 20(6):495-503. PubMed ID: 10672773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.